APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,879,015 | -61.6% | 548,870 | -7.9% | 0.14% | -58.8% |
| Q2 2023 | $54,316,735 | +3.9% | 596,232 | -24.7% | 0.34% | -6.5% |
| Q1 2023 | $52,256,546 | +46.6% | 792,246 | +14.9% | 0.37% | +34.2% |
| Q4 2022 | $35,652,856 | +194.4% | 689,477 | +74.3% | 0.28% | +219.8% |
| Q4 2019 | $12,110,000 | +71.0% | 395,490 | +34.6% | 0.09% | +50.9% |
| Q3 2019 | $7,080,000 | -26.9% | 293,901 | -23.1% | 0.06% | -21.9% |
| Q2 2019 | $9,685,000 | -32.1% | 382,212 | -47.7% | 0.07% | -33.0% |
| Q1 2019 | $14,263,000 | +40.8% | 731,451 | -4.7% | 0.11% | +26.7% |
| Q4 2018 | $10,128,000 | -7.0% | 767,876 | +25.4% | 0.09% | +13.2% |
| Q3 2018 | $10,887,000 | -18.5% | 612,296 | +0.9% | 0.08% | -24.0% |
| Q2 2018 | $13,353,000 | – | 606,956 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |